Biomedicines (Jul 2021)

Type II Collagen-Conjugated Mesenchymal Stem Cells Micromass for Articular Tissue Targeting

  • Shamsul Bin Sulaiman,
  • Shiplu Roy Chowdhury,
  • Mohd Fauzi Bin Mh Busra,
  • Rizal Bin Abdul Rani,
  • Nor Hamdan Bin Mohamad Yahaya,
  • Yasuhiko Tabata,
  • Yosuke Hiraoka,
  • Ruszymah Binti Haji Idrus,
  • Ng Min Hwei

DOI
https://doi.org/10.3390/biomedicines9080880
Journal volume & issue
Vol. 9, no. 8
p. 880

Abstract

Read online

The tissue engineering approach in osteoarthritic cell therapy often requires the delivery of a substantially high cell number due to the low engraftment efficiency as a result of low affinity binding of implanted cells to the targeted tissue. A modification towards the cell membrane that provides specific epitope for antibody binding to a target tissue may be a plausible solution to increase engraftment. In this study, we intercalated palmitated protein G (PPG) with mesenchymal stem cells (MSCs) and antibody, and evaluated their effects on the properties of MSCs either in monolayer state or in a 3D culture state (gelatin microsphere, GM). Bone marrow MSCs were intercalated with PPG (PPG-MSCs), followed by coating with type II collagen antibody (PPG-MSC-Ab). The effect of PPG and antibody conjugation on the MSC proliferation and multilineage differentiation capabilities both in monolayer and GM cultures was evaluated. PPG did not affect MSC proliferation and differentiation either in monolayer or 3D culture. The PPG-MSCs were successfully conjugated with the type II collagen antibody. Both PPG-MSCs with and without antibody conjugation did not alter MSC proliferation, stemness, and the collagen, aggrecan, and sGAG expression profiles. Assessment of the osteochondral defect explant revealed that the PPG-MSC-Ab micromass was able to attach within 48 h onto the osteochondral surface. Antibody-conjugated MSCs in GM culture is a potential method for targeted delivery of MSCs in future therapy of cartilage defects and osteoarthritis.

Keywords